Literature DB >> 15087778

Eosinophilia correlates with the presence or development of chronic graft-versus-host disease in children.

David A Jacobsohn1, Tali Schechter, Roopa Seshadri, Kimberly Thormann, Reggie Duerst, Morris Kletzel.   

Abstract

Finding predictors of chronic graft-versus-host disease (cGVHD) in children would be extremely useful. Because of recent data suggesting that cGVHD may be a Th-2-mediated process, a theoretical foundation linking eosinophilia and cGVHD exists. While an association between eosinophilia and cGVHD has been described in adults, it has never been described in children. We studied 53 patients that received allogeneic hematopoietic stem cell transplants (SCT) between 1999 and 2002. Ten (19%) of these patients developed eosinophilia (absolute eosinophil count (AEC) > 500x 10/L) after day 100. Of these ten, eight either had or later developed cGVHD. We conclude that following the peripheral eosinophil count in children post-SCT is useful, and a rise in the AEC may herald the development of cGVHD. Taking the AEC into account with other risk factors (such as previous grade II-IV acute GVHD, human leukocyte antigen (HLA)-mismatch, and unrelated donor (URD) transplant) may improve our ability to predict cGVHD.

Entities:  

Mesh:

Year:  2004        PMID: 15087778     DOI: 10.1097/01.tp.0000118409.92769.fa

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

Review 1.  Biomarkers in chronic graft-versus-host disease.

Authors:  Jacob Rozmus; Kirk R Schultz
Journal:  Expert Rev Hematol       Date:  2011-06       Impact factor: 2.929

2.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.

Authors:  Paul A Carpenter; Carrie L Kitko; Sharon Elad; Mary E D Flowers; Juan C Gea-Banacloche; Jörg P Halter; Flora Hoodin; Laura Johnston; Anita Lawitschka; George B McDonald; Anthony W Opipari; Bipin N Savani; Kirk R Schultz; Sean R Smith; Karen L Syrjala; Nathaniel Treister; Georgia B Vogelsang; Kirsten M Williams; Steven Z Pavletic; Paul J Martin; Stephanie J Lee; Daniel R Couriel
Journal:  Biol Blood Marrow Transplant       Date:  2015-03-31       Impact factor: 5.742

3.  Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report.

Authors:  Stephanie J Lee; Daniel Wolff; Carrie Kitko; John Koreth; Yoshihiro Inamoto; Madan Jagasia; Joseph Pidala; Attilio Olivieri; Paul J Martin; Donna Przepiorka; Iskra Pusic; Fiona Dignan; Sandra A Mitchell; Anita Lawitschka; David Jacobsohn; Anne M Hall; Mary E D Flowers; Kirk R Schultz; Georgia Vogelsang; Steven Pavletic
Journal:  Biol Blood Marrow Transplant       Date:  2015-03-19       Impact factor: 5.742

Review 4.  Chronic graft-versus-host disease (GVHD) in children.

Authors:  Kristin Baird; Kenneth Cooke; Kirk R Schultz
Journal:  Pediatr Clin North Am       Date:  2010-02       Impact factor: 3.278

Review 5.  New approaches for preventing and treating chronic graft-versus-host disease.

Authors:  Stephanie J Lee
Journal:  Blood       Date:  2005-02-08       Impact factor: 22.113

6.  National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis.

Authors:  Kristin Baird; Seth M Steinberg; Lana Grkovic; Drazen Pulanic; Edward W Cowen; Sandra A Mitchell; Kirsten M Williams; Manuel B Datiles; Rachel Bishop; Carol W Bassim; Jacqueline W Mays; Dean Edwards; Kristen Cole; Daniele N Avila; Tiffany Taylor; Amanda Urban; Galen O Joe; Leora E Comis; Ann Berger; Pamela Stratton; Dan Zhang; James H Shelhamer; Juan C Gea-Banacloche; Claude Sportes; Daniel H Fowler; Ronald E Gress; Steven Z Pavletic
Journal:  Biol Blood Marrow Transplant       Date:  2013-01-20       Impact factor: 5.742

7.  Nail dystrophy, edema, and eosinophilia: harbingers of severe chronic GVHD of the skin in children.

Authors:  J T Huang; C N Duncan; D Boyer; H Khosravi; L E Lehmann; A Saavedra
Journal:  Bone Marrow Transplant       Date:  2014-09-22       Impact factor: 5.483

Review 8.  Evaluation and differential diagnosis of marked, persistent eosinophilia.

Authors:  Thomas B Nutman
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

9.  Regression of eosinophil counts after diagnosis of chronic graft-versus-host disease as a potential marker for improved clinical outcome.

Authors:  Fabian Beier; Klaus Arbter; Nicolai A Kittan; Reinhard Andreesen; Stefan W Krause; Ernst Holler; Gerhard C Hildebrandt
Journal:  Mol Clin Oncol       Date:  2013-09-25

Review 10.  Eosinophilic disorders in various diseases.

Authors:  Jocelyn Celestin; Marianne Frieri
Journal:  Curr Allergy Asthma Rep       Date:  2012-02       Impact factor: 4.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.